open-access
25+ Million Readerbase Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles
image image image image
Google Scholar citation report
Citations : 17406

Systematic Reviews in Pharmacy received 17406 citations as per google scholar report

Flyer image
Systematic Reviews in Pharmacy peer review process verified at publons
Flyer image

Indexed In

Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review

Abstract

Faiqah Umar, Mochammad Hatta, Dirayah Rauf Husain, Burhanuddin Bahar, Agussalim Bukhari, Ressy Dwiyanti, Ade Rifka Junita, Muhammad Reza Primaguna

Resistance to antituberculosis (anti-TB) drugs is a growing global problem, which is not only related to the high level of HIV co-infection. However, it can also be caused by the presence of multi-, extensively-, and totally drug-resistant Mycobacterium tuberculosis strain, hence the choice of using anti-TB drugs is getting smaller. The mechanism of emergence of drug-resistant bacterial strains is due to the mutation of drug target genes, decreased barrier permeability, and increased efflux rate. Drug resistance due to increased efflux pump activity is caused by overexpression of efflux pump genes, and amino acid substitution in protein, making efflux pump activity more efficient. Both mechanisms cause a reduction in intracellular anti-TB concentration so that the organism becomes less susceptible to the drug component. Number of studies have been conducted to explore components that can inhibit the action of bacterial efflux pump. Verapamil is a blocker of Ca2+, a prototype of the phenylalkalylamine group that has the potential to inhibit the efflux pump of M. tuberculosis bacteria to be more susceptible to anti-TB drugs both in vivo and in vitro. The study of new components or a combination of adjuvant components and anti-TB drugs to treat drug-resistant M. tuberculosis infections is the main goal in the development of more effective TB treatment strategies.

How to Cite this Article
Pubmed Style

Umar F, Hatta M, Husain DR, Bahar B, Bukhari A, Dwiyanti R, Junita AR, Primaguna MR. Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. SRP. 2019; 10(1): s43-s48. doi:10.5530/srp.2019.1s.22

Web Style

Umar F, Hatta M, Husain DR, Bahar B, Bukhari A, Dwiyanti R, Junita AR, Primaguna MR. Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. http://www.sysrevpharm.org/?mno=302644526 [Access: March 30, 2021]. doi:10.5530/srp.2019.1s.22

AMA (American Medical Association) Style

Umar F, Hatta M, Husain DR, Bahar B, Bukhari A, Dwiyanti R, Junita AR, Primaguna MR. Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. SRP. 2019; 10(1): s43-s48. doi:10.5530/srp.2019.1s.22


Vancouver/ICMJE Style

Umar F, Hatta M, Husain DR, Bahar B, Bukhari A, Dwiyanti R, Junita AR, Primaguna MR. Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. SRP. (2019), [cited March 30, 2021]; 10(1): s43-s48. doi:10.5530/srp.2019.1s.22


Harvard Style

Umar, F., Hatta, . M., Husain, . D. R., Bahar, . B., Bukhari, . A., Dwiyanti, . R., Junita, . A. R. & Primaguna, . M. R. (2019) Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. SRP, 10 (1), s43-s48. doi:10.5530/srp.2019.1s.22


Turabian Style

Umar, Faiqah, Mochammad Hatta, Dirayah Rauf Husain, Burhanuddin Bahar, Agussalim Bukhari, Ressy Dwiyanti, Ade Rifka Junita, and Muhammad Reza Primaguna. 2019. Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. Systematic Reviews in Pharmacy, 10 (1), s43-s48. doi:10.5530/srp.2019.1s.22


Chicago Style

Umar, Faiqah, Mochammad Hatta, Dirayah Rauf Husain, Burhanuddin Bahar, Agussalim Bukhari, Ressy Dwiyanti, Ade Rifka Junita, and Muhammad Reza Primaguna. "Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review." Systematic Reviews in Pharmacy 10 (2019), s43-s48. doi:10.5530/srp.2019.1s.22


MLA (The Modern Language Association) Style

Umar, Faiqah, Mochammad Hatta, Dirayah Rauf Husain, Burhanuddin Bahar, Agussalim Bukhari, Ressy Dwiyanti, Ade Rifka Junita, and Muhammad Reza Primaguna. "Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review." Systematic Reviews in Pharmacy 10.1 (2019), s43-s48. Print. doi:10.5530/srp.2019.1s.22


APA (American Psychological Association) Style

Umar, F., Hatta, . M., Husain, . D. R., Bahar, . B., Bukhari, . A., Dwiyanti, . R., Junita, . A. R. & Primaguna, . M. R. (2019) Verapamil as an Efflux Inhibitor Against Drug Resistant Mycobacterium Tuberculosis: A Review. Systematic Reviews in Pharmacy, 10 (1), s43-s48. doi:10.5530/srp.2019.1s.22

ARTICLE TOOLS
Submit Article
Login
Register
Scan Code
Most Viewed Articles
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Psychometric properties of the World Health Organization Quality of life instrument, short form: Validity in the Vietnamese healthcare context Trung Quang Vo*, Bao Tran Thuy Tran, Ngan Thuy Nguyen, Tram ThiHuyen Nguyen, Thuy Phan Chung Tran SRP. 2020; 11(1): 14-22 » doi: 10.5530/srp.2019.1.3
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • Deuterium Depleted Water as an Adjuvant in Treatment of Cancer Anton Syroeshkin, Olga Levitskaya, Elena Uspenskaya, Tatiana Pleteneva, Daria Romaykina, Daria Ermakova SRP. 2019; 10(1): 112-117 » doi: 10.5530/srp.2019.1.19
Most Downloaded
  • Dental Development between Assisted Reproductive Therapy (Art) and Natural Conceived Children: A Comparative Pilot Study Norzaiti Mohd Kenali, Naimah Hasanah Mohd Fathil, Norbasyirah Bohari, Ahmad Faisal Ismail, Roszaman Ramli SRP. 2020; 11(1): 01-06 » doi: 10.5530/srp.2020.1.01
  • Manilkara zapota (L.) Royen Fruit Peel: A Phytochemical and Pharmacological Review Karle Pravin P, Dhawale Shashikant C SRP. 2019; 10(1): 11-14 » doi: 0.5530/srp.2019.1.2
  • Pharmacognostic and Phytopharmacological Overview on Bombax ceiba Pankaj Haribhau Chaudhary, Mukund Ganeshrao Tawar SRP. 2019; 10(1): 20-25 » doi: 10.5530/srp.2019.1.4
  • A Review of Pharmacoeconomics: the key to “Healthcare for All” Hasamnis AA, Patil SS, Shaik Imam, Narendiran K SRP. 2019; 10(1): s40-s42 » doi: 10.5530/srp.2019.1s.21
  • A Prospective Review on Phyto-Pharmacological Aspects of Andrographis paniculata Govindraj Akilandeswari, Arumugam Vijaya Anand, Palanisamy Sampathkumar, Puthamohan Vinayaga Moorthi, Basavaraju Preethi SRP. 2019; 10(1): 15-19 » doi: 10.5530/srp.2019.1.3